ClinicalTrialsFinder

Angiotensin Receptor/Neprilysin Inhibitor Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 4

Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease

Coronary Artery DiseaseIschemic Mitral RegurgitationAngiotensin Receptor/Neprilysin Inhibitor
China National Center for Cardiovascular Diseases220 enrolled1 locationNCT06917664